BackgroundEnd-stage kidney disease patients continue to have markedly increased
cardiovascular disease morbidity and mortality. Analysis of genetic factors
connected with the renin-angiotensin system that influences the survival of
the patients with end-stage kidney disease supports the ongoing search for
improved outcomes.ObjectiveTo assess survival and its association with the polymorphism of
renin-angiotensin system genes: angiotensin I-converting enzyme
insertion/deletion and angiotensinogen M235T in patients undergoing
hemodialysis.MethodsOur study was designed to examine the role of renin-angiotensin system genes.
It was an observational study. We analyzed 473 chronic hemodialysis patients
in four dialysis units in the state of Rio de Janeiro. Survival rates were
calculated by the Kaplan-Meier method and the differences between the curves
were evaluated by Tarone-Ware, Peto-Prentice, and log rank tests. We also
used logistic regression analysis and the multinomial model. A p value
≤ 0.05 was considered to be statistically significant. The local
medical ethics committee gave their approval to this study.ResultsThe mean age of patients was 45.8 years old. The overall survival rate was
48% at 11 years. The major causes of death were cardiovascular diseases
(34%) and infections (15%). Logistic regression analysis found statistical
significance for the following variables: age (p = 0.000038), TT
angiotensinogen (p = 0.08261), and family income greater than five times the
minimum wage (p = 0.03089), the latter being a protective factor.ConclusionsThe survival of hemodialysis patients is likely to be influenced by the TT of
the angiotensinogen M235T gene.